# Sinovac Biotech (SVA) — News

SVA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sva/news

## Recent headlines

- [Tern - Announces settlement with general partner of SVV2 for all claims and liabilities](https://www.ainvest.com/news/tern-announces-settlement-general-partner-svv2-claims-liabilities-2610) — AInvest Wire, Oct 12, 2026
- [Sinovac H1 gross profit USD 95.536 million](https://www.ainvest.com/news/sinovac-h1-gross-profit-usd-95-536-million-2608) — AInvest Wire, Aug 17, 2026
- [Sinovac H1 pretax profit USD -69.839 million](https://www.ainvest.com/news/sinovac-h1-pretax-profit-usd-69-839-million-2608) — AInvest Wire, Aug 17, 2026
  Sinovac Biotech Ltd. (NASDAQ: SVA) reported unaudited financial results for the first half of 2023, revealing a pretax loss of USD -69.839 million for the six months ended June 30, 2023, compared to pretax income of USD 926.408 million in the same period in 2022. This decline was primarily…
- [Sinovac reports unaudited first half of 2026 financial results](https://www.ainvest.com/news/sinovac-reports-unaudited-2026-financial-results-2608) — AInvest Wire, Aug 17, 2026
- [Sinovac H1 basic EPS USD -0.84](https://www.ainvest.com/news/sinovac-h1-basic-eps-usd-0-84-2608) — AInvest Wire, Aug 17, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).